Repligen | RGEN - SCHULD

Aktienkurs
118.98
Täglich Wechseln
3.69 3.20%
Monatlich
-6.97%
Jährlich
-3.93%
Q2 Prognose
114.23




SCHULD Veränderung Datum
Agilent USD 3.35B 55M 2025-09
Align Technology USD 121.27M 1.75M 2025-09
Bio Techne USD 260M 40M 2025-12
BioMarin Pharmaceutical USD 604.24M 375K 2025-09
Bristol-Myers Squibb USD 51.04B 112M 2025-09
Bruker USD 2.01B 426.8M 2025-09
Charles River Laboratories USD 2.63B 157.4M 2025-09
Danaher USD 18.42B 1.56B 2025-12
Dentsply International USD 2.48B 14M 2025-09
General Electric Aerospace USD 20.49B 344M 2025-12
Henry Schein USD 3.44B 83M 2025-09
Illumina USD 2.58B 22M 2025-09
IQVIA Holdings USD 15.72B 767M 2025-12
Mettler Toledo International USD 2.21B 25.94M 2025-09
Myriad Genetics USD 59.3M 19.7M 2025-03
OraSure Technologies USD 782K 465K 2024-06
Pacific Biosciences Of California USD 892.24M 653K 2023-12
Pfizer USD 60.85B 78M 2025-09
Repligen USD 542.21M 146.65M 2025-12
Revvity USD 3.37B 5.86M 2025-09
Standard Biotools USD 27.39M 1.23M 2025-09
Thermo Fisher Scientific USD 35.68B 451M 2025-09
Waters USD 1.49B 52.2M 2025-09
West Pharmaceutical Services USD 202.8M 100K 2025-12